Validity of patient-derived disability and clinical data in multiple sclerosis

Multiple Sclerosis

Volumn 16, Issue 4, 2010, Pages 472-479

  Ingram, G ^a   Colley, E ^a   Ben Shlomo, Y ^b   Cossburn, M ^a   Hirst, C L ^a   Pickersgill, T P ^a   Robertson, N P ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Disability; Expanded Disability Status Scale; Multiple sclerosis; Outcome measurement; Phenotype; Questionnaire

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DISABILITY; DISEASE COURSE; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMPORT DISEASE; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT CODING; PROSPECTIVE STUDY; QUESTIONNAIRE; RECURRENCE RISK; SELF CONCEPT; TELEPHONE; ALGORITHM; HOSPITALIZATION; MIDDLE AGED; ONSET AGE; PREDICTION AND FORECASTING; REPRODUCIBILITY; RISK; TIME; UNITED KINGDOM; VALIDATION STUDY;

AGE OF ONSET; ALGORITHMS; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; ODDS RATIO; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; WALES;

EID: 77954687780     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509358902     Document Type: Article

References (32)

1. Hirst C, Ingram G, Swingler R, Compston DA, Pickersgill T, Robertson N. P. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis. J Neurol Neurosurg Psychiatry 2008;79:1137-1143.
2. Compston A, Coles A. Multiple sclerosis. Lancet 2002;359:1221-1231.
3. Bronnum-Hansen H, Koch-Henriksen N, Hyllested K. Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey. Neurology 1994;44:1901-1907.
4. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993;116:117-134.
5. Weinshenker BG, Bass B, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989;112:1419-1428. (Pubitemid 20024212)
6. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006;129:606-616. (Pubitemid 43278223)
7. Confavreux C, Vukusic S, Moreau T, Adeleine P, et al. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000;343:1430-1438.
8. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991;114:1045-1056.
9. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-1452.
10. Bowen J, Gibbons L, Gianas A, Kraft GH. Self-administered Expanded Disability Status Scale with functional system scores correlates well with a physician-administered test. Mult Scler 2001;7:201-206.
11. Lechner-Scott J, Kappos L, Hofman M, et al. Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 2003;9:154-159.
12. Cheng EM, Hays RD, Myers LW, Ellison GW, Beckstrand M, Vickrey BG. Factors related to agreement between self-reported and conventional Expanded Disability Status Scale (EDSS) scores. Mult Scler 2001;7:405-410.
13. Hirst CL, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of Multiple Sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009;80(4):386-391.
14. McDonald WI, Compston WIA, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
15. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
16. Parry O, Thomson C, Fowkes G. Life course data collection: qualitative interviewing using the life grid. Socio Res Online 1999;4(2) : http://www.socresonline.org.uk/socresonline/4/2/parry.html
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
18. Goodkin DE, Cookfair D, Wende K, et al. Inter-and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS). Multiple Sclerosis Collaborative Research Group. Neurology 1992;42:859-863.
19. Solari A, Amato MP, Bergamaschi R, et al. Accuracy of self-assessment of the minimal record of disability in patients with multiple sclerosis. Acta Neurol Scand 1993;87:43-46.
20. Verdier-Taillefer MH, Roullet MHE, Cesaro P, Alperovitch A. Validation of self-reported neurological disability in multiple sclerosis. Int J Epidemiol 1994;23:148-154.
21. Goodin DS. A questionnaire to assess neurological impairment in multiple sclerosis. Mult Scler 1998;4:444-451.
22. Thompson AJ, Hobart JC. Multiple sclerosis: assessment of disability and disability scales. J Neurol 1998;245:189-196.
23. Hoogervorst EL, van Winsen LM, Eikelenboom MJ, Kalkers NF, Uitdehaag BM, Polman CH. Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Neurology 2001;56:934-937.
24. Hoogervorst EL, Zwemmer JN, Jelles B, Polman CH, Uitdehaag BM. Multiple Sclerosis Impact Scale (MSIS-29) : relation to established measures of impairment and disability. Mult Scler 2004;10:569-574.
25. Hoogervorst EL, Eikelenboom MJ, Uitdehaag BM, Polman CH. One year changes in disability in multiple sclerosis: neurological examination compared with patient self report. J Neurol Neurosurg Psychiatry 2003;74:439-442.
26. Hoogervorst EL, Kalkers NF, Cutter GR, Uitdehaag BM, Polman CH. The patient's perception of a (reliable) change in the Multiple Sclerosis Functional Composite. Mult Scler 2004;10:55-60.
27. Hoogervorst EL, Kalkers NF, van Winsen LML, Uitdehaag BM, Polman CH. Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis. Mult Scler 2001;7:335-339.
28. Collen FM, Wade DT, Robb GF, Bradshaw CM. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud 1991;13:50-54.
29. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12). Neurology 2003;60:31-36.
30. Pearson OR, Busse ME, van Deursen RW, Wiles CM. Quantification of walking mobility in neurological disorders. QJM 2004;97:463-475.
31. Sharrack B, Hughes RA. Reliability of distance estimation by doctors and patients: cross sectional study. Br Med J 1997;315:1652-1654.
32. Bamer AM, Cetin D, Amtmann D, Bowen JD, Johnson KL. Comparing a self report questionnaire with physician assessment for determining multiple sclerosis clinical disease course: a validation study. Mult Scler 2007;13:1033-1037.